Final report on phase i trial of WR-2721 before protracted fractionated radiation therapy
- 30 June 1988
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 14 (6), 1119-1122
- https://doi.org/10.1016/0360-3016(88)90387-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Detection and Measurement of the Disulfide WR33278 [NH2(CH2)3NHCH2CH2S-]2in Blood and TissuesJournal of Liquid Chromatography, 1987
- Human pharmacokinetics of WR-2721International Journal of Radiation Oncology*Biology*Physics, 1986
- Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and TissuesJournal of Liquid Chromatography, 1986
- A Liquid Chromatographic Electrochemical Assay for S-2-(3-Aminopropylamino) Ethylphosphorothioate (WR2721) in Human PlasmaJournal of Liquid Chromatography, 1984
- Toxicity of WR-2721 administered in single and multiple dosesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radioprotection of tumor and normal tissues by thiophosphate compoundsCancer, 1973
- Cysteine Protection against X IrradiationScience, 1949